StockNews.com Downgrades Sherwin-Williams (NYSE:SHW) to Hold

Sherwin-Williams (NYSE:SHW) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Other analysts also recently issued research reports about the company. Evercore ISI raised their price objective on Sherwin-Williams from $365.00 to $380.00 and gave the stock an “outperform” rating in a research note on Friday, August 30th. KeyCorp lifted their price objective on Sherwin-Williams from $400.00 to $410.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Wells Fargo & Company increased their target price on Sherwin-Williams from $320.00 to $350.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 24th. Redburn Atlantic upgraded shares of Sherwin-Williams to a “strong-buy” rating in a report on Thursday, July 18th. Finally, Robert W. Baird upped their price target on shares of Sherwin-Williams from $310.00 to $325.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $369.00.

Sherwin-Williams Trading Down 0.3 %

NYSE SHW opened at $382.73 on Friday. Sherwin-Williams has a 12 month low of $232.06 and a 12 month high of $385.25. The stock has a 50-day simple moving average of $359.69 and a 200 day simple moving average of $329.68. The company has a current ratio of 0.81, a quick ratio of 0.50 and a debt-to-equity ratio of 2.17. The company has a market capitalization of $96.55 billion, a PE ratio of 40.80, a P/E/G ratio of 3.00 and a beta of 1.17.

Sherwin-Williams (NYSE:SHW) last announced its quarterly earnings results on Tuesday, July 23rd. The specialty chemicals company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.51 by $0.19. The business had revenue of $6.27 billion for the quarter, compared to the consensus estimate of $6.33 billion. Sherwin-Williams had a net margin of 10.92% and a return on equity of 75.58%. Sherwin-Williams’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the company posted $3.29 EPS. Research analysts forecast that Sherwin-Williams will post 11.47 EPS for the current year.

Insider Buying and Selling

In other Sherwin-Williams news, CFO Allen J. Mistysyn sold 14,520 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the transaction, the chief financial officer now owns 63,520 shares in the company, valued at approximately $23,301,041.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Waterloo Capital L.P. bought a new position in Sherwin-Williams during the 4th quarter worth $360,000. Valeo Financial Advisors LLC increased its position in shares of Sherwin-Williams by 7.9% in the second quarter. Valeo Financial Advisors LLC now owns 2,636 shares of the specialty chemicals company’s stock worth $787,000 after purchasing an additional 193 shares during the period. Massmutual Trust Co. FSB ADV raised its stake in Sherwin-Williams by 7.2% in the first quarter. Massmutual Trust Co. FSB ADV now owns 1,533 shares of the specialty chemicals company’s stock valued at $532,000 after purchasing an additional 103 shares in the last quarter. Brevan Howard Capital Management LP lifted its position in Sherwin-Williams by 259.1% during the fourth quarter. Brevan Howard Capital Management LP now owns 6,998 shares of the specialty chemicals company’s stock worth $2,183,000 after purchasing an additional 5,049 shares during the period. Finally, Transcend Capital Advisors LLC grew its stake in Sherwin-Williams by 24.1% during the second quarter. Transcend Capital Advisors LLC now owns 7,805 shares of the specialty chemicals company’s stock worth $2,329,000 after buying an additional 1,514 shares in the last quarter. 77.67% of the stock is owned by institutional investors.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.